… clinical challenge Head and neck cancers account for about 5% of all cancers worldwide. …
) being the backbone for small and operable tumors. However, a significant subset of patients …

Background: Head and neck cancers (HNCs) continue to remain a significant public health
burden worldwide, causing significant mortality and morbidity despite significant clinical …

… the therapeutic landscape in head and neck cancer. However, … As far as the head and neck
cancer is concerned, all pivotal … At present no data from the real life is available in this setting…

… Various tumor antigens (Ly6K, CDCA1, IMP3…) that have been identified in non-HPV head
and neck cancer have been shown to elicit TL response in humans [95]. Patients showing a …

… oligometastasis in head and neck cancer. We also describe the challenges and opportunities
in … free of disease 4–5 years after, raising the real possibility of cure in some patients [58]. …

… Liquid biopsy has been increasingly considered as an option for molecular characterization
and detection of cancer as it can provide real-time information about cancer in a minimally …

… Due to alteration of patient anatomy, changes in tissue density/volumes and tumor shrinkage
over the course of treatment, treatment accuracy may be challenged. This may result in …

… of immunoradiotherapy in head and neck cancer are discussed. The … tumors. However, the
trials using immunoradiotherapy in patients with recurrent or metastatic head and neck cancer …

… head and neck cancers is cause for great concern, particularly in Central-Eastern Europe.
The great majority of these cancers … lesions and early invasive cancers; however, no study as …

… Figure 2 depicts a real-life patient positioning for HNC … Challenging fields of research could
be not only the decrease of … the specific and challenging indication of head and neck cancer. …